Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma

Yan Zhou, Yang Dong, Qingcheng Yang, Xiaobin Lv, Wentao Huang, Zhenhua Zhou, Yaling Wang, Zhichang Zhang, Ting Yuan, Xiaomin Ding, Lina Tang, Jianjun Zhang, Junyi Yin, Yujing Huang, Wenxi Yu, Yonggang Wang, Chenliang Zhou, Su Yang, Aina He, Yuanjue Sun, Zan Shen, Bin‐Zhi Qian, Wei Meng, Jia Fei, Yang Yao, and 3 more

View at source ↗PDF ↗Article671 citations

Abstract

Abstract Osteosarcoma is the most frequent primary bone tumor with poor prognosis. Through RNA-sequencing of 100,987 individual cells from 7 primary, 2 recurrent, and 2 lung metastatic osteosarcoma lesions, 11 major cell clusters are identified based on unbiased clustering of gene expression profiles and canonical markers. The transcriptomic properties, regulators and dynamics of osteosarcoma malignant cells together with their tumor microenvironment particularly stromal and immune cells are characterized. The transdifferentiation of malignant osteoblastic cells from malignant chondroblastic cells is revealed by analyses of inferred copy-number variation and trajectory. A proinflammatory FABP4 + macrophages infiltration is noticed in lung metastatic osteosarcoma lesions. Lower osteoclasts infiltration is observed in chondroblastic, recurrent and lung metastatic osteosarcoma lesions compared to primary osteoblastic osteosarcoma lesions. Importantly, TIGIT blockade enhances the cytotoxicity effects of the primary CD3 + T cells with high proportion of TIGIT + cells against osteosarcoma. These results present a single-cell atlas, explore intratumor heterogeneity, and provide potential therapeutic targets for osteosarcoma.

Abstract of "Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma" by Yan Zhou, Yang Dong, Qingcheng Yang et al., https://doi.org/10.1038/s41467-020-20059-6, used under its Creative Commons Attribution license (CC-BY); markup removed, otherwise unmodified.

Record

Archive ID
doi:10.1038/s41467-020-20059-6
Published
Dec 10, 2020
Venue
Nature Communications
DOI
10.1038/s41467-020-20059-6
PubMed
33303760
PMC
PMC7730477
Categories
Sarcoma Diagnosis and Treatment
License
cc-by
Provenance
openalex+europepmc

Topics